The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Symbicort was produced by AstraZeneca and Astellas.
Sales in AZ’s respiratory franchise were also better-than-expected, with sales of asthma treatment Symbicort (budesonide and formoterol fumarate dihydrate) increasing by 12% to bring in $653m – around $90m
For instance, in the UK, US, Canada and Spain, the first treatment was an ICS/LABA, such Seretide or Symbicort, while in Germany it was a bronchodilator.
In that role, he led the development of Symbicort, a leading respiratory brand.
AZ’s respiratory franchise also grew 18% to $1.3bn – although the company saw a 4% decline in sales of Symbicort, this was offset by the growth of Pulmicort and Fasenra,
reduction versus older drug Symbicort (formoterol fumarate/budesonide).
Graphite is a digital agency which partners with globally respected pharma and healthcare organisations to create powerful digital experiences. We...